 |
|
Red blood cell transfusions under scrutiny
November 27, 2007New research reveals potential harm
Bristol scientists have found that red blood cell transfusions given to people having heart surgery could increase the risk of heart attack or stroke.
Published in the latest issue [November 27] of the journal Circulation, the study looked at the association between red blood cell transfusion and adverse outcomes in over 8,500 cardiac surgery patients over eight years.
The research, funded by the British Heart Foundation (BHF), found patients who received a red blood cell transfusion experienced a three-fold increase in complications arising from lack of oxygen to key organs - such as in a heart attack or stroke. This is a finding at odds with the widely held belief that red cell transfusion improves delivery of oxygen to tissues.
The study, by scientists at the University of Bristol and the Bristol Heart Institute, showed that the risks associated with transfusion occurred regardless of the haemoglobin levels (the oxygen-carrying substance in red blood cells), age, or level of patient disability at the time of transfusion.
Professor Peter Weissberg, Medical Director at the BHF says: "Red blood cells carry oxygen around the body to supply vital organs. Not unreasonably therefore, heart surgeons have assumed that patients who have low red blood cell counts after surgery - as a result of blood loss during or shortly after surgery - would benefit from a 'top up' transfusion of donated red blood cells.
"This study shows the importance of putting such widespread beliefs to the test since it suggests that such transfusions may cause more problems than they solve. The results are a step towards making heart surgery even safer by flagging up an issue we can now address through research and improved transfusion guidelines."
As well as the human costs, the financial cost of giving transfusions and treating transfusion-related illnesses increased the overall cost of staying in hospital by over 40 per cent.
Gavin Murphy, Walport Consultant Senior Lecturer in Cardiac Surgery at the University of Bristol, who led the study said; "This study demonstrates the cost implications of our current transfusion practice. This is important, particularly in modern health systems where resources are finite, and should encourage the sort of research that will address the major health issues raised in the study."
In the UK over half of all heart surgery patients are given blood. However, only about 3 per cent of these transfusions are given because of life-threatening bleeding. The remainder are usually given on the basis of a low haemoglobin level, regardless of whether the patient has physical symptoms to suggest they need blood.
The researchers now intend to carry out a larger study to see if changing transfusion guidelines could improve patient outcomes. For the time being it is suggested that surgeons think twice before giving their patients a transfusion.
More research is needed to find out how red cell transfusions may affect immunity or tissue oxygenation to cause these harmful effects, and to determine how stored donor blood products may be made safer prior to transfusion.
University of Bristol
The research, funded by the British Heart Foundation (BHF), found patients who received a red blood cell transfusion experienced a three-fold increase in complications arising from lack of oxygen to key organs - such as in a heart attack or stroke. This is a finding at odds with the widely held belief that red cell transfusion improves delivery of oxygen to tissues.
The study, by scientists at the University of Bristol and the Bristol Heart Institute, showed that the risks associated with transfusion occurred regardless of the haemoglobin levels (the oxygen-carrying substance in red blood cells), age, or level of patient disability at the time of transfusion.
Professor Peter Weissberg, Medical Director at the BHF says: "Red blood cells carry oxygen around the body to supply vital organs. Not unreasonably therefore, heart surgeons have assumed that patients who have low red blood cell counts after surgery - as a result of blood loss during or shortly after surgery - would benefit from a 'top up' transfusion of donated red blood cells.
"This study shows the importance of putting such widespread beliefs to the test since it suggests that such transfusions may cause more problems than they solve. The results are a step towards making heart surgery even safer by flagging up an issue we can now address through research and improved transfusion guidelines."
As well as the human costs, the financial cost of giving transfusions and treating transfusion-related illnesses increased the overall cost of staying in hospital by over 40 per cent.
Gavin Murphy, Walport Consultant Senior Lecturer in Cardiac Surgery at the University of Bristol, who led the study said; "This study demonstrates the cost implications of our current transfusion practice. This is important, particularly in modern health systems where resources are finite, and should encourage the sort of research that will address the major health issues raised in the study."
In the UK over half of all heart surgery patients are given blood. However, only about 3 per cent of these transfusions are given because of life-threatening bleeding. The remainder are usually given on the basis of a low haemoglobin level, regardless of whether the patient has physical symptoms to suggest they need blood.
The researchers now intend to carry out a larger study to see if changing transfusion guidelines could improve patient outcomes. For the time being it is suggested that surgeons think twice before giving their patients a transfusion.
More research is needed to find out how red cell transfusions may affect immunity or tissue oxygenation to cause these harmful effects, and to determine how stored donor blood products may be made safer prior to transfusion.
University of Bristol
Red Blood Cell Current Events and Red Blood Cell News RSSMalaria's key survival protein identified, offering drug hope
Walter and Eliza Hall Institute researchers have identified a key protein used by the malaria parasite to transform human red blood cells, ensuring the parasite's survival.
Scientists find ideal target for malaria therapy
Scientists at Washington University School of Medicine in St. Louis have identified a protein made by the malaria parasite that is essential to its ability to take over human red blood cells.
Waiting for birth or inducing found equally effective for women with IUGR
In a study to be presented today at the Society for Maternal-Fetal Medicine's (SMFM) annual meeting, The Pregnancy Meeting ™, in Chicago, researchers will unveil findings that show that waiting for birth is as effective as inducing labor in cases of intrauterine growth restriction (IUGR).
Research breakthrough could lead to new treatment for malaria
Malaria causes more than two million deaths each year, but an expert multinational team battling the global spread of drug-resistant parasites has made a breakthrough in the search for better treatment. Better understanding of the make-up of these parasites and the way they reproduce has enabled an international team, led by John Dalton, a biochemist in McGill's Institute of Parasitology, to identify a plan of attack for the development of urgently needed new treatments.
New Insight into Selective Binding Properties of Infectious HIV
Free infectious HIV-1 is widely thought to be the major form of the virus in the blood of infected persons.
Measuring and modeling blood flow in malaria
When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells.
Small nanoparticles bring big improvement to medical imaging
If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
Drugs to treat anemia in cancer patients linked to thromboembolism
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center.
Scientists successfully reprogram blood cells
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
Findings show nanomedicine promising for treating spinal cord injuries
Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident.
More Red Blood Cell Current Events and Red Blood Cell News Articles
 |
GIANT Microbes - Red Blood Cell (Erythrocyte) - Plush Toy by Giant Microbes The life of the party, his best trick is to hold his breath until he turns blue! Invite him to your next bash and he's sure show you a bloody good time. |
|
Immune Destruction of Red Blood Cells by Sandra Taddie Nance (Editor) | |
 |
Ein-O Science BioSigns Red Blood Cell by Tedco The hands on cell and microbiology models provide magnified and cross section details. The set includes Virus, Bacteria, Plant Cell, White Blood Cell, Red Blood Cell and Animal Cell. Ein-O's I Know Guides and storage box are included. Consider using these models with a display of your own making - featuring the intricacies of cell structure, comparing and contrasting differences, investigating functions & interactions, or describing the efforts of modern medicine... a neat Science Fair Project. Virus - This hands-on interactive model provides magnified and cross-sectioned detailing of a Virus. Animal Cell - This hands-on interactive model provides magnified and cross-sectioned detailing of an Animal Cell. White Blood Cell - This hands-on interactive model provides... |
 |
Nature Made Iron 65mg Equivalent to 325 mg Ferrous Sulfate, Vital for Red Blood Cell Formation, Dietary Supplement, 300 Tablets Each (2 Pack) by Nature Made Iron has a central role in transporting oxygen to important tissues throughout the body. It is also needed for the formation and function of hemoglobin in red blood cells and myoglobin in muscle cells, which are necessary for the transportation of oxygen. Iron helps prevent iron-deficiency anemia, a condition in which red blood cells are not able to carry enough oxygen to meet the bodys needs. It is the most common deficiency in the United States and the most common cause of anemia in the U.S., especially among children and women during their childbearing years (Mahan & Stump, 2008). Symptoms of anemia include fatigue, poor concentration, and an increase in colds and infections, so with that said, it is critical that iron needs are met. In addition, iron helps strengthen the immune... |
 |
Natural TF-Defense - Support iron absorption & maintain red blood cell integrity in pets by PetAlive What is TF-Defense? TF-Defense combines natural ingredients that are known for their supportive function on red blood cells and liver health. It will also support a healthy immune system functioning. |
 |
6pk - Globulo Rojo - Red Blood Cell Support - Tablets by De La Cruz Description: Globulo Rojo tablets contain a high potency formula which provides a rich source of Iron, Vitamin B Complex and Vitamin B-12, Vitamin C, Liver and Zinc. Iron is a critical component of the red blood cells and thus supports the energy of the entire body. B-Complex vitamins support healthy nerves, eyes, skin and hair. Vitamin C and Zinc are powerful anti-oxidants that aid immune system function. Directions: Adults take one tablet morning and night with food. Children 6-12, take one tablet daily with food. 60 Tablets |
 |
CELL MODEL - RED BLOOD by TEDCO TOYS This hands-on interactive model provides magnified and cross-sectioned detailing of a red blood cell. Includes Ein-O's I Know Guide. OVERSIZED MULTI-COLORED |
 |
The Life of a Red Blood Cell (Revised) DVD by AIMS Multimedia This humorous animated film introduces children to the circulatory system as a new red blood cell is made in the bone marrow and joins others in a vein. |
 |
Enfamil ProSobee Lipil Soy Infant Formula, Iron Fortified, Powder (Case Pack, Six-12.9 Ounce Cans) by Enfamil For Baby's First 12 Months. Makes 92 fl oz. Milk-free, lactose-free. A blend of DHA & ARA - Nutrients found in breast milk. Milk-free; Lactose-free; Iron-fortified. Lipil is a blend of the nutrients DHA and ARA. DHA and ARA are also naturally found in breast milk and are important building blocks for a baby's brain and eyes. Experts agree on the many benefits of breast milk. If you choose to use infant formula, ask your doctor which Enfamil formula is best for your baby. Enfamil ProSobee Lipil is a soy formula for babies who are fussy or develop gas or diarrhea due to lactose sensitivity. It's easy-to-digest, complete and balanced nutrition for baby's first 12 months of life. |
 |
You were a single red blood cell but I lost you in this knot of capillaries Wise Children (Primary Contributor) |
| © 2010 BrightSurf.com |